* Amdocs Ltd DOX.OQ DOX.O is expected to show a rise in
quarterly revenue when it reports results on November 8.
* The Chesterfield Missouri Missouri-based company is
expected to
report a 7.2% increase in revenue to $1.165 billion from $1.09
billion a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. The company's guidance on
August 3 2022, for the period ended September 30, was for
revenue between $1.15 billion and $1.19 billion.
* Refinitiv's mean analyst estimate for Amdocs Ltd is for
earnings of $1.29 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Amdocs Ltd
is
$93.5, above its last closing price of $81.60.
The company's guidance on August 3 2022 for the period ended
September 30 was for Earnings before Interest and Taxes between
USD200.375 million and USD207.375 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 1.27 1.27 1.27 Met 0.3
Mar. 31 2022 1.25 1.25 1.54 Beat 23.3
Dec. 31 2021 1.18 1.18 1.20 Beat 1.4
Sep. 30 2021 1.18 1.18 1.16 Missed -1.4
Jun. 1.19 1.18 1.35 Beat 14.4
30 2021
Mar. 31 2021 1.13 1.13 1.13 Met -0.2
Dec. 31 2020 1.14 1.14 1.16 Beat 2.1
Sep. 30 2020 1.18 1.19 1.23 Beat 3.8
This summary was machine generated November 5 at 03:09 GMT. All
figures in US dollars unless otherwise stated